Predialysis: initially 0.25mcg daily; may increase to 0.5mcg daily. Dialysis: initially 0.25mcg daily; may increase by 0.25mcg daily at 4–8 week intervals; usual maintenance: 0.5–1mcg daily.

Calcitriol (Rocaltrol Capsule) is a synthetic vitamin D analog, prescribed for hypocalcemia in patients undergoing chronic renal dialysis.It helps proper absorption and use of calcium and phosphate in ...

PRINCETON, N.J., Sept. 2 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with Validus ...

BANGALORE, Sept 3 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd said on Thursday it would launch in the United States a generic version of Rocaltrol used in the treatment of ailments arising ...

To observe the efficacy and safety of Rocaltrol (calcitriol) and/or Caltrate D (calicum carbonate plus vitamin D) in elderly Chinese women with osteopenia or osteoporosis. This was a multi-center, ...

Ranbaxy Pharmaceuticals Inc, a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has entered into an agreement with Validus Pharmaceuticals LLC to market and distribute an authorised ...

Ranbaxy Laboratories on Thursday has said it has entered into an agreement with US-based Validus Pharma for selling low cost versions of its calcium drug Rocaltrol. The company’s US-based subsidiary ...

Agreement with Validus Pharmaceuticals to Market and Distribute Multiple Formulations in the U.S. Healthcare System PRINCETON, N.J., Sept. 2 -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned ...